Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
69.1M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
53.3M
-
Shares change
-
+4.85M
-
Total reported value, excl. options
-
$2.67B
-
Value change
-
+$240M
-
Put/Call ratio
-
0.26
-
Number of buys
-
113
-
Number of sells
-
-67
-
Price
-
$50.01
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q3 2021
230 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.3M shares
of 69.1M outstanding shares and own 77.13% of the company stock.
Largest 10 shareholders include FMR LLC (7.44M shares), BlackRock Inc. (4.68M shares), VANGUARD GROUP INC (4.12M shares), Capital Research Global Investors (3.12M shares), WELLINGTON MANAGEMENT GROUP LLP (2.88M shares), ALLIANCEBERNSTEIN L.P. (2.19M shares), Clearbridge Investments, LLC (2.16M shares), JANUS HENDERSON GROUP PLC (1.4M shares), VICTORY CAPITAL MANAGEMENT INC (1.22M shares), and RIVERBRIDGE PARTNERS LLC (1.07M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.